Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

6%

1 of 16 completed with results

Key Signals

1 with results94% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (2)
P 1 (1)
P 2 (4)
P 3 (3)

Trial Status

Completed16
Unknown3
Active Not Recruiting1
Terminated1
Withdrawn1

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT00007150Phase 2Active Not RecruitingPrimary

Treatment of Hemochromatosis

NCT03743272Completed

Repeatability and Reproducibility of Multiparametric MRI

NCT02025543Completed

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

NCT04631718CompletedPrimary

MRI QSM Imaging for Iron Overload

NCT01892644Phase 2WithdrawnPrimary

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

NCT06137079Unknown

"Iron Overload and Endocrinological Diseases"

NCT00001203Completed

Deferoxamine for the Treatment of Hemochromatosis

NCT00199628Completed

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

NCT03654794CompletedPrimary

Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells

NCT00712738Phase 1Completed

Oral Nifedipine to Treat Iron Overload

NCT00005541Completed

Hemochromatosis and Iron Overload Screening Study (HEIRS)

NCT00005559Completed

Statistical Basis for Hemochromatosis Screening

NCT00587535CompletedPrimary

Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration

NCT00006312Completed

Hemochromatosis--Genetic Prevalence and Penetrance

NCT00000595Phase 2Completed

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

NCT00122980Phase 3TerminatedPrimary

Stroke With Transfusions Changing to Hydroxyurea

NCT00350662Phase 3CompletedPrimary

Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients

NCT01524757Not ApplicableUnknownPrimary

Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis

NCT00349453Phase 2CompletedPrimary

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

NCT00202436Phase 3CompletedPrimary

Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy

Scroll to load more

Research Network

Activity Timeline